Red clover Trifolium pratense L.
Also called: cow clover, meadow clover, wild clover
Red clover is a legume native to Europe, central Asia and northern Africa. It contains isoflavones, compounds structurally similar to estrogen; Health Canada's monograph covers standardized isoflavone extracts made from the flower, herb top and leaf.
- Category
- Botanical
- Part used
- Flower, herb top and leaf, as standardized isoflavone extracts
- Strongest evidence
- B Some positive trials
- Native range
- Native from Macaronesia and northwest Africa through Europe to Mongolia and the Himalaya (POWO: "Macaronesia, NW. Africa, Europe to Mongolia and Himalaya"); introduced in many other regions
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2021 meta-analysis pooled eight placebo-controlled RCTs (ten comparisons) on daily hot flashes; per its Table 1 and references, seven tested red clover isoflavone extract alone and one (Lambert 2017) combined it with probiotics. [5]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CSeveral areas, whole body or blood1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Hot flashes in peri- and postmenopausal women | B | A 2026 meta-analysis of nine placebo-controlled RCTs (37.1–160 mg/day isoflavones, 12 weeks to 12 months) found a small-to-moderate reduction in hot-flash frequency; most trials had low risk of bias. [4] |
| Daily number of hot flashes | B | A 2021 meta-analysis of eight trials (ten comparisons) found 1.73 fewer hot flashes per day than placebo (95% CI -3.28 to -0.18); the authors call for further well-designed studies. [5] |
| Blood lipids in peri- and postmenopausal women | B | A 2020 meta-analysis of ten studies (910 women) found lower total cholesterol (-0.29 mmol/L) but no significant change in LDL, HDL or triglycerides, with high heterogeneity between studies. [6] |
| Overall evidence (NCCIH summary) | C | NCCIH: research has not shown conclusive benefit for any condition; hot-flash studies had inconsistent results, some with high risk of bias, and findings on cholesterol were conflicting. [1] |
| Bone density in postmenopausal women | C | NCCIH: only a small number of studies have been done on bone density in postmenopausal women, and the results have been inconsistent. [1] |
Main constituents: Isoflavones, structurally similar to estrogen [1]; Isoflavones biochanin A, genistein, formononetin and daidzein (potencies may be declared for each, in mg aglycone isoflavone equivalents) [3]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Trials in the 2026 meta-analysis used 37.1 to 160 mg isoflavones daily for 12 weeks to 12 months. [4]
- Health Canada monograph (May 29, 2026): 40–100 mg total aglycone isoflavone equivalents per day from standardized extracts, for peri- and postmenopausal women; consult a practitioner for use beyond 1 year. [3]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNCCIH: red clover supplements may be unsafe for use during pregnancy or while breastfeeding.
2 statements in the profile.
Details and sources - Interactions with medicines4 listed
Warfarin and other anticoagulants or antiplatelet drugs; Methotrexate; Drugs metabolized by CYP1A2, 2C8, 2C9, 2C19, 2D6 and 3A4 …
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Health Canada, Red Clover Isoflavone Extract monograph (May 29, 2026), oral, peri- and postmenopausal women: standardized extracts providing 40-100 …
Details and sources
- Red clover extracts have been used in clinical studies for as long as 2 years with apparent safety and appear to be well tolerated. [1]
- Red clover supplements may be unsafe during pregnancy or while breastfeeding. [1]
- MSK: people with hormone-sensitive cancers should avoid red clover because it has estrogenic activity. [2]
- Health Canada monograph: do not use if you have or had breast cancer or tumors or a predisposition to breast cancer (abnormal mammogram or biopsy, or a family member with breast cancer). [3]
- Case reports: subdural hematoma in a 65-year-old woman whose only bleeding risk factor was long-term red clover use; subarachnoid hemorrhage in a 53-year-old woman taking a product with red clover, dong quai and Siberian ginseng. [2]
- Health Canada label statement: stop use and ask a practitioner if new symptoms develop, such as breast pain, a recurrence of menstruation or uterine spotting. [3]
Interactions
| With | What happens |
|---|---|
| Warfarin and other anticoagulants or antiplatelet drugs | MSK: red clover may increase bleeding risk with warfarin; preclinical studies suggest it may increase the effects of anticoagulants and antiplatelets, with clinical relevance not yet determined. [2] |
| Methotrexate | Red clover was reported to cause toxicity (severe vomiting and epigastric pain) when used along with methotrexate injections. [2] |
| Drugs metabolized by CYP1A2, 2C8, 2C9, 2C19, 2D6 and 3A4 | Preclinical studies suggest red clover can inhibit these enzymes; clinical relevance has yet to be determined. [2] |
| Hormone replacement therapy | Health Canada: ask a practitioner before use if you are taking any hormone replacement therapy. [3] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Health Canada requires the total isoflavone content to be expressed on the label in milligrams of aglycone isoflavone equivalents (AIE). [3]
Regulatory status
- US: by law, FDA does not approve dietary supplements or their labeling before they are marketed. [7]
- US food use: 21 CFR 182.10 and 182.20 list clover (Trifolium spp.) among spices, flavorings and natural extractives generally recognized as safe for their intended use. [8]
- Canada: Health Canada's Red Clover Isoflavone Extract monograph (May 29, 2026) covers oral standardized extracts for menopausal symptoms and bone mineral density loss in postmenopausal women. [3]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming Trifolium pratense (red clover) (earliest NDI 177 submitted 2002-08-26; most recent NDI 191 submitted 2003-01-21). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P4]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Warfarin and other anticoagulants or antiplatelet drugs: MSK: red clover may increase bleeding risk with warfarin; preclinical studies suggest it may increase the effects of anticoagulants and antiplatelets (clinical relevance not yet determined). [P2]
- Methotrexate: MSK: red clover was reported to cause toxicity, with severe vomiting and epigastric pain, when used with methotrexate injections. [P2]
- Drugs metabolized by CYP1A2, 2C8, 2C9, 2C19, 2D6 and 3A4: MSK: preclinical studies suggest inhibition of these enzymes; clinical relevance has yet to be determined. [P2]
- Hormone replacement therapy: Health Canada: ask a health care practitioner before use if you are taking any hormone replacement therapy. [P3]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — US cGMP rule for dietary supplements: at least one appropriate test or examination must verify the identity of any component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)); exemption only through a petition FDA grants (111.75(a)(1)(ii)). [P5]
- Total isoflavone assay expressed as mg aglycone isoflavone equivalents (AIE); optional assay of biochanin A, genistein, formononetin and daidzein — Health Canada's monograph requires total isoflavone content on the label in mg AIE and allows declared potencies for individual isoflavones. [P3]
Supply and conservation
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Health Canada, Red Clover Isoflavone Extract monograph (May 29, 2026), oral, peri- and postmenopausal women: standardized extracts providing 40-100 mg total aglycone isoflavone equivalents per day; ask a practitioner for use beyond 1 year. [P3]
Sources for this profile
- NCCIH. Red Clover: Usefulness and Safety (Last Updated: April 2025), 2025-04. nccih.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Red Clover (Last Updated February 10, 2022), 2022-02-10. mskcc.org
- Health Canada, NNHPD. Monograph: Red Clover Isoflavone Extract (dated May 29, 2026), 2026-05-29. webprod.hc-sc.gc.ca
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23; checked 2026-10-29), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list, TR-001 to TR-606 (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- GBIF species API: IUCN Red List category for Trifolium pratense L., 2026-10-29. api.gbif.org
Sources
- NCCIH. Red Clover: Usefulness and Safety (Last Updated: April 2025), 2025-04. nccih.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Red Clover (Last Updated February 10, 2022), 2022-02-10. mskcc.org
- Health Canada, NNHPD. Monograph: Red Clover Isoflavone Extract (dated May 29, 2026), 2026-05-29. webprod.hc-sc.gc.ca
- Jiang W, Wu K. The effectiveness of red clover on hot-flash in menopausal women: a GRADE-assessed systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2026;324:115226 (PMID 42269521), 2026-08. pubmed.ncbi.nlm.nih.gov
- Kanadys W, et al. Evaluation of clinical meaningfulness of red clover (Trifolium pratense L.) extract to relieve hot flushes and menopausal symptoms: a systematic review and meta-analysis of randomized controlled trials. Nutrients 2021;13(4):1258 (PMID 33920485), 2021-04-11. pubmed.ncbi.nlm.nih.gov
- Kanadys W, et al. Effects of red clover (Trifolium pratense) isoflavones on the lipid profile of perimenopausal and postmenopausal women: a systematic review and meta-analysis. Maturitas 2020;132:7-16 (PMID 31883666), 2020-02. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- eCFR. 21 CFR 182.10 Spices and other natural seasonings and flavorings, and 182.20 Essential oils, oleoresins (solvent-free), and natural extractives (version of October 23, 2026), 2026-10-23. ecfr.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Trifolium pratense L. (accessed 2026-10-29), 2026-10-29. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.